ILT-101 in Patients With Active Moderate to Severe Systemic Lupus Erythematosus (SLE) March 5, 2019https://clinicaltrials.gov/ct2/show/NCT02955615?type=Intr&cond=Lupus&phase=012345&lupd_s=02%2F19%2F2019&lupd_d=14 [Read more…] about ILT-101 in Patients With Active Moderate to Severe Systemic Lupus Erythematosus (SLE)
